|Last Price||Today's Change||52-Week Range||Trading Volume|
|0.07 CAD||0.00 (-6.67%)||0.025 - 0.085||20.0 thousand|
Market data as of 3:43PM 12/06/13. Quotes are delayed by at least 15 min.
Quest PharmaTech strengthens its Antibody Immunotherapy Technology by licensing anti-MUC1 IgE Technology from Stanford University; Researchers to present late-breaking data at the 28th Annual Meeting of the Society for Immunotherapy of Cancer to be held November 8 - 10, 2013 in Maryland, U.S.
PR Newswire - Thursday 11/07/2013 9:30 AM ET
|Revenue Growth (1yr)||--|
|Net Income Growth (1yr)||--|
Data is delayed by at least 15 min.